Vericiguat
Back to searchMolecule Structure
Scientific Name
Vericiguat
Description of the Drug
Vericiguat is a soluble guanylate cyclase stimulator used to reduce heart failure-related hospitalization and cardiovascular death in patients with chronic systolic heart failure.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB15456
http://www.drugbank.ca/drugs/DB15456
Brand Name(s)
Verquvo
Company Owner(s)
Merck Sharp And Dohme Corp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Soluble guanylate cyclase | PROTEIN COMPLEX GROUP | ACTIVATOR | CHEMBL2111348 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL429958 |
| Human Metabolome Database | HMDB0304849 |
| DrugBank | DB15456 |
| PubChem: Thomson Pharma | 131471128 |
| PubChem | 54674461 |
| Nikkaji | J3.590.750E |
| BindingDB | 50239781 |
| DrugCentral | 5439 |
| ChemicalBook | CB83033102 |
| Guide to Pharmacology | 10010 |
| ChEBI | 142432 |
| ZINC | ZINC000072318626 |
